Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Structured Neuromuscular Exercise Program (nmep-run)

12. maj 2026 opdateret af: Elif Tunç

The Effect of s Structured Neuromuscular Exercise Program on Running Performance and Lower Extremity Biomechanics in Recreational Runners

This randomized controlled trial aims to investigate the effects of an 8-week structured neuromuscular exercise program on running performance and lower extremity biomechanics in recreational runners. The program includes progressive exercises focusing on hip and core strength, balance, plyometric control, and running-specific mobility. Participants will be randomly assigned to an intervention or control group. The intervention group will perform the neuromuscular training twice a week for eight weeks, while the control group will not receive any structured exercise. Pre- and post-intervention assessments will include biomechanical analysis and functional performance tests. The study aims to provide evidence for the preventive and performance-enhancing benefits of neuromuscular training in runners.

Studieoversigt

Detaljeret beskrivelse

Running is a repetitive and high-impact activity that places significant mechanical stress on the lower extremities. Improper movement patterns, muscle imbalances, and reduced neuromuscular control have been identified as key contributors to running-related injuries. Previous studies have demonstrated that neuromuscular training can enhance movement efficiency, improve joint stability, and reduce injury risk in athletic populations. However, there is limited evidence on the structured and progressive application of neuromuscular exercise programs specifically designed for recreational runners.

The present randomized controlled trial aims to evaluate the effects of an 8-week structured neuromuscular exercise program on running performance and lower extremity biomechanics in recreational runners. The intervention includes progressive exercises focusing on hip and core strength, dynamic balance, plyometric control, and running-specific mobility. Participants will be randomly assigned to either an intervention or control group. The intervention group will perform the neuromuscular training twice weekly under supervision, while the control group will maintain their usual physical activity routine. Biomechanical assessments and functional performance tests will be conducted before and after the intervention period. This study seeks to provide scientific evidence supporting the preventive and performance-enhancing benefits of neuromuscular training in runners, contributing to injury prevention and performance optimization strategies.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

24

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Age between 18 and 55 years

Recreational runners who have been running regularly (at least twice per week for the last 6 months)

No current musculoskeletal injury limiting running

Willing to participate in the 8-week neuromuscular exercise program and attend follow-up assessments

Able to provide informed consent

Exclusion Criteria:

  • History of lower limb surgery or fracture in the past 6 months

Neurological, vestibular, or systemic diseases affecting balance or gait

Current participation in a structured strength or neuromuscular training program

Pregnancy

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: NEUROMUSCULAR EXERCISE GROUP
Participants in this group will not receive any structured exercise program during the 8-week intervention period. They will maintain their usual physical activity and running habits. Assessments will be performed at the same pre- and post-intervention time points as the intervention group.
An 8-week structured neuromuscular exercise program including progressive exercises targeting hip and core strength, dynamic balance, plyometric control, and running-specific mobility. The program is performed twice per week under supervision. It is designed to improve running performance, neuromuscular control, and lower limb biomechanics in recreational runners.
Ingen indgriben: CONTROL GROUP
Participants in this group will not receive any structured exercise program during the 8-week intervention period. They will maintain their usual physical activity and running habits. Assessments will be performed at the same pre- and post-intervention time points as the intervention group.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Running performance
Tidsramme: Baseline and after 8 weeks of intervention
Change in running performance will be assessed using a standardized time-trial test to evaluate the effectiveness of the neuromuscular exercise program in improving endurance and speed in recreational runners.
Baseline and after 8 weeks of intervention

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Dynamic balance
Tidsramme: Baseline and after 8 weeks of intervention
Balance performance will be evaluated using the Y-Balance Test to determine improvements in postural control after the neuromuscular training intervention.
Baseline and after 8 weeks of intervention
Lower limb strength
Tidsramme: Baseline and after 8 weeks of intervention
hip abductor muscle strength will be measured using handheld dynamometry
Baseline and after 8 weeks of intervention

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. maj 2026

Primær færdiggørelse (Anslået)

1. september 2026

Studieafslutning (Anslået)

1. september 2026

Datoer for studieregistrering

Først indsendt

1. januar 2026

Først indsendt, der opfyldte QC-kriterier

12. maj 2026

Først opslået (Faktiske)

19. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

19. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

12. maj 2026

Sidst verificeret

1. januar 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data (IPD) will not be shared because the dataset includes identifiable physiological and biomechanical data collected from human participants. Data sharing is restricted by ethical approval and participant consent regulations. Only aggregated results will be reported in publications.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner